CC BY-NC-ND 4.0 · Sleep Sci
DOI: 10.1055/s-0044-1795145
Case Report

Altitude-Associated Central Apnea in Continuous Positive Airway Pressure Therapy

1   Sleep Medicine Center, Fundación Neumológica Colombiana, Bogota, Cundinamarca, Colombia
,
1   Sleep Medicine Center, Fundación Neumológica Colombiana, Bogota, Cundinamarca, Colombia
,
1   Sleep Medicine Center, Fundación Neumológica Colombiana, Bogota, Cundinamarca, Colombia
,
1   Sleep Medicine Center, Fundación Neumológica Colombiana, Bogota, Cundinamarca, Colombia
› Author Affiliations
Funding Source The author(s) received no financial support for the research.

Abstract

Introduction At high altitudes, hypobaric hypoxia leads to central apneas in both healthy adults and patients with obstructive sleep apnea. This condition correlates with intermittent desaturation and disruption of sleep.

Materials and Methods The clinical case of a patient evaluated during a sleep medicine outpatient consultation at the Fundación Neumológica Colombiana (Bogotá, Colombia, 2,600 masl) is reported.

Case Study We present a 64-year-old male patient living in a high-altitude city, who was an aircrew member and was on continuous positive airway pressure (CPAP) therapy for severe obstructive sleep apnea (OSA). The patient had symptoms and central apneas only when he slept at high altitudes. Other causes of central apnea were ruled out, and these events were corrected with the administration of supplemental oxygen. Altitude-associated central apnea is a common disorder that can occur at altitudes higher than 1,600 m above sea level. Currently, the first-line treatments are acetazolamide and oxygen supplementation.

Conclusions Changes in altitude should be considered in patients with OSA in PAP therapy, as it can occur in many occupations and in recreational travels.

Author Agreement Statement

We undersigned declare that this manuscript is original, has not been published before, and is not currently being considered for publication elsewhere. We confirm that the manuscript has been read and approved by all named authors and that there are no other persons who satisfied the criteria for authorship but are not listed.




Publication History

Received: 14 February 2024

Accepted: 02 October 2024

Article published online:
07 March 2025

© 2025. Brazilian Sleep Association. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

Bibliographical Record
Gustavo Adolfo Gaitan Quintero, Leidy Paola Prada Romero, Ana María González, María Angélica Bazurto-Zapata. Altitude-Associated Central Apnea in Continuous Positive Airway Pressure Therapy. Sleep Sci ; : s00441795145.
DOI: 10.1055/s-0044-1795145
 
  • References

  • 1 Badr MS, Dingell JD, Javaheri S. Central sleep apnea: A brief review. Curr Pulmonol Rep 2019; 8 (01) 14-21
  • 2 Randerath W, Verbraecken J, Andreas S. et al. Definition, discrimination, diagnosis and treatment of central breathing disturbances during sleep. Eur Respir J 2017; 49 (01) 1600959
  • 3 Bloch KE, Latshang TD, Ulrich S. Patients with Obstructive Sleep Apnea at Altitude. High Alt Med Biol 2015; 16 (02) 110-116
  • 4 Whitelaw W. Mechanisms of sleep apnea at altitude. Adv Exp Med Biol 2006; 588: 57-63
  • 5 Burgess KR, Ainslie PN. Central sleep apnea at high altitude. Adv Exp Med Biol 2016; 903: 275-283
  • 6 Rey de Castro J, Liendo A, Ortiz O, Rosales-Mayor E, Liendo C. Ventilatory cycle measurements and loop gain in central apnea in mining drivers exposed to intermittent altitude. J Clin Sleep Med 2017; 13 (01) 27-32
  • 7 Gilmartin GS, Daly RW, Thomas RJ. Recognition and management of complex sleep-disordered breathing. Curr Opin Pulm Med 2005; 11 (06) 485-493
  • 8 Gold AR, Bleecker ER, Smith PL. A shift from central and mixed sleep apnea to obstructive sleep apnea resulting from low-flow oxygen. Am Rev Respir Dis 1985; 132 (02) 220-223
  • 9 Nussbaumer-Ochsner Y, Latshang TD, Ulrich S, Kohler M, Thurnheer R, Bloch KE. Patients with obstructive sleep apnea syndrome benefit from acetazolamide during an altitude sojourn: a randomized, placebo-controlled, double-blind trial. Chest 2012; 141 (01) 131-138
  • 10 Liu HM, Chiang IJ, Kuo KN, Liou CM, Chen C. The effect of acetazolamide on sleep apnea at high altitude: a systematic review and meta-analysis. Ther Adv Respir Dis 2017; 11 (01) 20-29
  • 11 Schmickl CN, Landry SA, Orr JE. et al. Acetazolamide for OSA and central sleep apnea: A comprehensive systematic review and meta-analysis. Chest 2020; 158 (06) 2632-2645
  • 12 Pagel JF, Kwiatkowski C, Parnes B. The effects of altitude associated central apnea on the diagnosis and treatment of obstructive sleep apnea: comparative data from three different altitude locations in the mountain west. J Clin Sleep Med 2011; 7 (06) 610-5A
  • 13 Bazurto Zapata MA, Martinez-Guzman W, Vargas-Ramirez L, Herrera K, Gonzalez-Garcia M. Prevalence of central sleep apnea during continous positive airway pressure (CPAP) titration in subjects with obstructive sleep apnea syndrome at an altitude of 2640 m. Sleep Med 2015; 16 (03) 343-346